Taizhou Hospital of Traditional Chinese Medicine, Taizhou Jiangsu 225300, China.
Taixing People's Hospital, Taizhou, Jiangsu 225400, China.
J Healthc Eng. 2021 Oct 27;2021:6940056. doi: 10.1155/2021/6940056. eCollection 2021.
Noninvasive or minimally invasive interventional surgery was selected, and the complications were less and had no significant impact on the quality of life of patients. Tumour patients are often accompanied by cerebrovascular diseases, metabolic diseases, and other basic diseases, which more or less adversely affect the surgical efficacy of tumour. In this paper, endovascular remobilization was used to treat tumour; the basic condition of patients before operation and the interventional operation plan were introduced. Through the analysis of clinical data and prognosis evaluation results of tumour patients receiving intravascular interventional therapy, the patients were divided into good prognosis group and poor prognosis group according to the modified Rankin scale score at discharge. The relationship between gender, age, history of hypertension, tumour width, tumour size, preoperative Hunt-Hess grade, interventional surgery method, and prognosis related to intravascular interventional therapy was explored. The results showed that intravascular interventional therapy for tumour patients can obtain a good prognosis, which provides a reference for the future preoperative assessment of treatment risk and possible prognosis and provides a theoretical basis for the formulation of treatment plan to improve prognosis.
选择了非侵入性或微创介入手术，并发症较少，对患者的生活质量没有显著影响。肿瘤患者常伴有脑血管疾病、代谢性疾病等基础疾病，或多或少地影响肿瘤的手术疗效。本文采用血管内再通术治疗肿瘤；介绍了患者术前的基本情况和介入手术方案。通过对接受血管内介入治疗的肿瘤患者的临床资料和预后评估结果进行分析，根据出院时改良Rankin 量表评分将患者分为预后良好组和预后不良组。探讨了性别、年龄、高血压病史、肿瘤宽度、肿瘤大小、术前 Hunt-Hess 分级、介入手术方法与血管内介入治疗预后的关系。结果表明，肿瘤患者的血管内介入治疗可获得良好的预后，为今后治疗风险和可能预后的术前评估提供了参考，并为制定改善预后的治疗方案提供了理论依据。
